Hospital Departamental de Villavicencio
Villavicencio, Meta Department, 50001, Colombia
Location status: Recruiting
NCT Number: NCT07208110
In this study, it was planned to establish the factors associated with severe trauma discharged from the intensive care unit and mortality. A cross-sectional trial will be conducted to review the ICU discharge database at a two-year interval to review records of trauma admissions patients and compare them with other types of admissions. Participant institutions are general hospitals (public and private) from the Colombian Orinoco region. the prevalence of admission by trauma will also be determined.
Interested in participating?
Request Info15 year–100 year
All sexes
Observational
Villavicencio, Meta Department, 50001, Colombia
Location status: Recruiting
Introduction Trauma is the main cause of mortality and disability in young population worldwide. The violence and vehicle accidents are the most common mechanism, depending on regional context. Severe cases require admission to the intensive care unit usually. Comprehension of such the factors associated with trauma mortality will allow to optimize, prioritize and improve limited resources, by stratifying the risk, and focus therapeutic strategies, with a potential reduction on mortality, cost, and sequalae. The study aims to analyze the factors associated with outcomes in patients with severe trauma admitted to the intensive care unit.
Methodology An analytical cross-sectional trial will be performed, based on the review of discharge database in the intensive care unit during the period of study. The study will be performed in Hospital Departamental de Villavicencio and Clinica Primavera from January 2022 and December 2024. Al records from discharges will be reviewed to establish those related to trauma indications; the records will be divided in two groups for comparisons between the care after trauma and other admissions. Demographic variables of severity and diagnosis will be analyzed. The outcomes to evaluate will be mortality and ICU length of stay.
Expected results The cause of admission by trauma, severity scores by diagnostic groups, and the outcomes by type of trauma will be highlighted with this trial. With the advance of this research, we expect that predictive variables for mortality in trauma, polytrauma, and major trauma in the ICU, will be revealed, and a predictive model adjusted to the local context of the population cared will be established.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Patients exposed to trauma previous to the admission to the ICU.
Patients not exposed to trauma previous to the admission to the ICU.
Time frame: 30 days
Discharge by death or within 30 days of ICU length of stay.
Time frame: 30 days
Length of stay in the intensive care unit.
Contact information is provided by the study sponsor or research team.
Emma I Rodriguez Darabos, MSc
CONTACT
Norton Perez Gutierrez, MD
CONTACT
Hospital Departamental de Villavicencio
Other
Factors Associated With Mortality by Trauma in the Intensive Care Unit in Villavicencio, Colombia. A Trial Based on a Discharge Registry.
Acronym: MOTRAM-ICU-COL
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07268716
Accidental Injuries, EQ5D5L-VAS
Bergen, Norway
View Trial DetailsNCT07492511
Cardiovascular Diseases, Edema
Bologna, Italy
View Trial DetailsNCT07193524
Fractures, Bone, Leg Injuries
Boston, Massachusetts, United States
View Trial DetailsNCT07411976
Critical Illness, Disease Attributes
Nîmes, France
View Trial Details